BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35333910)

  • 1. Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein.
    Arora P; Sidarovich A; Graichen L; Hörnich B; Hahn A; Hoffmann M; Pöhlmann S
    PLoS One; 2022; 17(3):e0265453. PubMed ID: 35333910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
    Sasaki M; Uemura K; Sato A; Toba S; Sanaki T; Maenaka K; Hall WW; Orba Y; Sawa H
    PLoS Pathog; 2021 Jan; 17(1):e1009233. PubMed ID: 33476327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.
    Barrett CT; Neal HE; Edmonds K; Moncman CL; Thompson R; Branttie JM; Boggs KB; Wu CY; Leung DW; Dutch RE
    J Biol Chem; 2021 Jul; 297(1):100902. PubMed ID: 34157282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
    Minami S; Kotaki T; Sakai Y; Okamura S; Torii S; Ono C; Motooka D; Hamajima R; Nouda R; Nurdin JA; Yamasaki M; Kanai Y; Ebina H; Maeda Y; Okamoto T; Tachibana T; Matsuura Y; Kobayashi T
    Microbiol Spectr; 2024 Apr; 12(4):e0285923. PubMed ID: 38415690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
    Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
    ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
    Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
    J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
    Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
    Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry.
    Wang K; Pan Y; Wang D; Yuan Y; Li M; Chen Y; Bi L; Zhang XE
    Virol Sin; 2023 Aug; 38(4):595-605. PubMed ID: 37343929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.
    Escalera A; Laporte M; Turner S; Karakus U; Gonzalez-Reiche AS; van de Guchte A; Farrugia K; Khalil Z; van Bakel H; Smith D; García-Sastre A; Aydillo T
    Emerg Microbes Infect; 2024 Dec; 13(1):2297553. PubMed ID: 38112266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
    Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
    Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells.
    Katte RH; Ao Y; Xu W; Han Y; Zhong G; Ghimire D; Florence J; Tucker TA; Lu M
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype.
    Park SB; Khan M; Chiliveri SC; Hu X; Irvin P; Leek M; Grieshaber A; Hu Z; Jang ES; Bax A; Liang TJ
    Commun Biol; 2023 May; 6(1):556. PubMed ID: 37225764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.